Document Detail

Treatment of portal hypertension.
MedLine Citation:
PMID:  22468079     Owner:  NLM     Status:  MEDLINE    
Portal hypertension is the main complication of cirrhosis and is defined as an hepatic venous pressure gradient (HVPG) of more than 5 mmHg. Clinically significant portal hypertension is defined as HVPG of 10 mmHg or more. Development of gastroesophageal varices and variceal hemorrhage are the most direct consequence of portal hypertension. Over the last decades significant advancements in the field have led to standard treatment options. These clinical recommendations have evolved mostly as a result of randomized controlled trials and consensus conferences among experts where existing evidence has been reviewed and future goals for research and practice guidelines have been proposed. Management of varices/variceal hemorrhage is based on the clinical stage of portal hypertension. No specific treatment has shown to prevent the formation of varices. Prevention of first variceal hemorrhage depends on the size/characteristics of varices. In patients with small varices and high risk of bleeding, non-selective β-blockers are recommended, while patients with medium/large varices can be treated with either β-blockers or esophageal band ligation. Standard of care for acute variceal hemorrhage consists of vasoactive drugs, endoscopic band ligation and antibiotics prophylaxis. Transjugular intrahepatic portosystemic shunt (TIPS) is reserved for those who fail standard of care or for patients who are likely to fail ("early TIPS"). Prevention of recurrent variceal hemorrhage consists of the combination of β-blockers and endoscopic band ligation.
Khurram Bari; Guadalupe Garcia-Tsao
Related Documents :
8147619 - Ischemia-dependent efficacy of phosphodiesterase inhibition.
8633949 - Improved cardiac function after prolonged hypothermic ischemia with the na+/h+ exchange...
1711609 - Effect of inosine on function and adenine nucleotide content of the isolated working ra...
7979679 - Ischemic preconditioning improves preservation with crystalloid cardioplegia.
18269389 - Administration of milrinone before ischemia, in the presence of beta-blockade, to treat...
8945679 - Attenuation of myocardial stunning in isolated rat hearts by a 21-aminosteroid lazaroid...
14653039 - Anal canal pressure in anal fissure before and after internal sphincterotomy.
3723179 - Subtle deterioration in shunted childhood hydrocephalus. a biomechanical and clinical p...
16935599 - Esterified estrogens combined with methyltestosterone raise intraocular pressure in pos...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  18     ISSN:  2219-2840     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-04-02     Completed Date:  2012-05-15     Revised Date:  2014-05-20    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  1166-75     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use
Clinical Trials as Topic
Consensus Development Conferences as Topic
Esophageal and Gastric Varices / complications
Gastrointestinal Hemorrhage / etiology,  therapy
Hypertension, Portal / therapy*
Portasystemic Shunt, Transjugular Intrahepatic
Reg. No./Substance:
0/Adrenergic beta-Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Management of non-variceal upper gastrointestinal tract hemorrhage: controversies and areas of uncer...
Next Document:  Management of portal hypertension in children.